Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
The cuprizone model: regional heterogeneity of pathology.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
An analytical model for estimating water exchange rate in white matter using diffusion MRI.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
Treatment of Acute Disseminated Encephalomyelitis.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
Differential Cerebellar Functional Interactions during an Interference Task across Multiple Sclerosis Phenotypes.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.
How can we exploit the brain's ability to repair itself?
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Atomic view of a toxic amyloid small oligomer.
The mechanism of action of interferon-β in relapsing multiple sclerosis.
Iron in multiple sclerosis: roles in neurodegeneration and repair.
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Pages
« first
‹ previous
…
261
262
263
264
265
266
267
268
269
…
next ›
last »